Professor of infectious diseases, London University's Imperial College; PolyTherics
Sunil Shaunak is out to prove that academics can develop medicines for a fraction of what Big Pharma spends. His model is simple: Concoct a compound that resembles a patented drug, keeping it different enough to avoid legal problems. Then fund a startup with philanthropic grants, replacing every stage of traditional drugmaking with outsourced alternatives. His small biotech, PolyTherics, created a new hepatitis C medicine, which will undergo final testing this year. If it works, poor nations will have a hep C injection that costs $3 a pop rather than the current $200. --J.S.
If legendary inventor Ray Kurzweil is right, the future will be a lot brighter - and weirder - than you think. (more) 
See the full list of America's largest corporations, including detailed company profiles and contact information. (more) 
Just a few ways to be profitably and pleasantly (if uselessly) employed, from Stanley Bing's book, "100 Bulls**t Jobs ... and How to Get Them" (Harper Collins). (more) 
